Security AgreementSecurity Agreement • October 4th, 2018 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • Utah
Contract Type FiledOctober 4th, 2018 Company Industry JurisdictionThis Security Agreement (this “Agreement”), dated as of September 28, 2018, is executed by Hemispherx Biopharma, Inc., a Delaware corporation (“Debtor”), in favor of Iliad Research and Trading, L.P., a Utah limited partnership (“Secured Party”).
Securities Purchase AgreementSecurities Purchase Agreement • October 4th, 2018 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • Utah
Contract Type FiledOctober 4th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of September 28, 2018, is entered into by and between Hemispherx Biopharma, Inc., a Delaware corporation (“Company”), and Iliad Research and Trading, L.P., a Utah limited partnership, its successors and/or assigns (“Investor”).